. 2020 Oct 5;217(10):e20201261.
doi: 10.1084/jem.20201261.
Neutralizing hepatitis B
Davide F Robbiani 1
Affiliations
Affiliation
1
Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
PMID: 32790869 DOI: 10.1084/jem.20201261
Abstract
Despite an effective vaccine, hepatitis B virus (HBV) remains a major public health threat since chronic infection leads to liver disease and cancer. Hehle et al. (https://doi.org/10.1084/jem.20200840) discovered human-derived antibodies that potently neutralize the virus. Will this help a cure?